Open AccessHigh-dose ruthenium-106 plaque therapy for circumscribed choroidal hemangioma: a retrospective study of 25 Chinese patients
Author(s) -
Jing Li,
Enzhong Jin,
Jianhong Liang
Publication year - 2020
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2020.03.09
Subject(s) - medicine , hemangioma , visual acuity , retrospective cohort study , brachytherapy , fundus (uterus) , radiation therapy , ophthalmology , nuclear medicine , surgery
To evaluate the efficacy and safety of ruthenium-106 ( 106 Ru) plaque radiotherapy at a dose (>50 Gy) higher than recommended (29-50 Gy) for treatment of circumscribed choroidal hemangioma (CCH) in Chinese patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom